The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strasser, J. E.
Right arrow Articles by Dean, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strasser, J. E.
Right arrow Articles by Dean, G. E.
The Journal of Immunology, 1999, 162: 6148-6154.
Copyright © 1999 by The American Association of Immunologists

Regulation of the Macrophage Vacuolar ATPase and Phagosome-Lysosome Fusion by Histoplasma capsulatum1

Jane E. Strasser2,*, Simon L. Newman{dagger}, Georgianne M. Ciraolo{ddagger}, Randal E. Morris{ddagger}, Michael L. Howell{ddagger} and Gary E. Dean*

Departments of * Molecular Genetics, Biochemistry, and Microbiology; {dagger} Medicine, Division of Infectious Diseases; and {ddagger} Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, OH 45267


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Histoplasma capsulatum (Hc) maintains a phagosomal pH of about 6.5. This strategy allows Hc to obtain iron from transferrin, and minimize the activity of macrophage (Mø) lysosomal hydrolases. To determine the mechanism of pH regulation, we evaluated the function of the vacuolar ATPase (V-ATPase) in RAW264.7 Mø infected with Hc yeast or the nonpathogenic yeast Saccharomyces cerevisae (Sc). Incubation of Hc-infected Mø with bafilomycin, an inhibitor of the V-ATPase, did not affect the intracellular growth of Hc, nor did it affect the intraphagosomal pH. In contrast, upon addition of bafilomycin, phagosomes containing Sc rapidly changed their pH from 5 to 7. Hc-containing phagosomes had 5-fold less V-ATPase than Sc-containing phagosomes as quantified by immunoelectron microscopy. Furthermore, Hc-containing phagosomes inhibited phagolysosomal fusion as quantified by the presence of acid phosphatase, accumulation of LAMP2, and fusion with rhodamine B-isothiocyanate-labeled dextran-loaded lysosomes. Finally, in Hc-containing phagosomes, uptake of ferritin was equivalent to phagosomes containing Sc, indicating that Hc-containing phagosomes have full access to the early "bulk flow" endocytic pathway. Thus, Hc yeasts inhibit phagolysosomal fusion, inhibit accumulation of the V-ATPase in the phagosome, and actively acidify the phagosomal pH to 6.5 as part of their strategy to survive in Mø phagosomes.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Histoplasma capsulatum (Hc)3 is a dimorphic fungal pathogen that causes a broad spectrum of disease activity. The course of infection is mild in most immunocompetent individuals. However, Hc may produce progressive disseminated infections in immunocompromised individuals (1, 2, 3, 4, 5, 6, 7, 8).

Macrophages (Mø) play a dual role in host defense against Hc. Initially, Mø provide the fungus with an intracellular environment in which they can replicate (9, 10). Hc yeasts reside within nonactivated Mø phagosomes in which they multiply until the Mø are destroyed. Upon induction of cell-mediated immunity, activated Mø act as the final effector cells and destroy the yeasts (11). During their residence in Mø, Hc yeast does not appear to secrete any factors that globally affect Mø function, but rather control their intraphagosomal environment (12, 13).

In the P388D1 mouse Mø cell line, phagolysosomal (PL) fusion occurs normally (14), but the pH of Hc-containing phagosomes is 6.5 (13). In contrast, phagosomes containing zymosan or methanol-killed Hc acidify normally, maintaining a pH of 5.0 (13). Results of studies in mouse peritoneal Mø, as well as in the Mø cell line J774.2, support this conclusion (15). In contrast, in human Mø that have ingested Hc yeasts, PL fusion is fivefold less than that which occurs upon ingestion of Saccharomyces cerevisiae (Sc) (16), but the pH in the phagosome still is 6.5 (S. L. N. unpublished observations).

In human Mø, raising the pH of Hc-containing phagosomes with the weak base chloroquine results in killing and digestion of the intracellular Hc (17). The effect of chloroquine is reversed by iron nitriloacetate, an iron compound that is soluble at neutral to alkaline pH, but not by holotransferrin that releases iron only in an acidic environment (17). That these in vitro findings are applicable in vivo is demonstrated by the fact that chloroquine reduces the number of organisms in the spleens and livers of Hc-infected mice in a dose-dependent manner, and that chloroquine can protect mice from a lethal inoculum of Hc yeasts (17). Taken together, these data suggest that, to survive and multiply within Mø phagosomes, Hc requires phagosomal acidification low enough to acquire iron from transferrin, but also high enough to minimize the activity of lysosomal hydrolases.

The enzyme responsible for generating and maintaining the acidic pH in phagosomal and endosomal pathways is vacuolar ATPase (V-ATPase) (18, 19, 20). Current data suggest that there are two possible mechanisms that Hc might utilize to control phagosomal pH. First, Hc might alkalinize the phagosome to counteract the effects of the V-ATPase. This mechanism might operate in murine peritoneal Mø or P388D1 Mø in which PL fusion occurs normally. Second, Hc might inhibit the accumulation of functional VATPase in the phagosomal membrane either by inactivating the V-ATPase present in the phagosomal membrane (by direct interactions or by enhancing degradation of the enzyme) or by inhibiting fusion with vesicles containing the V-ATPase. In this case, the yeasts would be required to slightly acidify their environment to obtain a pH of 6.5. This mechanism might operate in human Mø in which PL fusion is limited (16).

To distinguish between these two mechanisms, bafilomycin, a specific inhibitor of the V-ATPase, was used to block V-ATPase function in RAW Mø. The results of these experiments demonstrate that Hc yeasts do not require the phagosomal V-ATPase to acidify the phagosome, and that they inhibit accumulation of the V-ATPase in the phagosomal membrane. Furthermore, we find that RAW Mø are similar in function to human Mø in that PL fusion does not occur normally after ingestion of Hc yeasts. Finally, we demonstrate that Hc-containing phagosomes have diminished access to the late endocytic pathway, but full access to the fluid phase.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

Bafilomycin was the generous gift of Prof. K. Altendorf (Universitat Osnabruck, Osnabruck, Germany). Fluorescein-conjugated and biotinylated secondary Abs were from Vector Laboratories (Burlingame, CA). HRP-coupled secondary Abs were from Amersham (Arlington Heights, IL). Paraformaldehyde and glutaraldehyde were from Electron Microscopy Sciences (Washington, PA). Eponate 12 was from Ted Pella (Redding, CA). All sera were from Hyclone (Logan, UT). All other reagents were reagent grade or better and were from Fisher Scientific (Pittsburgh, PA) or Sigma (St. Louis, MO).

Mø cell culture

RAW 264.7 cells (BALB/c mouse macrophage transformed with Abelson leukemia virus) from the American Type Culture Collection (Manasses, VA) were cultured in DMEM containing 4.5 g/L glucose supplemented with 10% heat-inactivated FBS (complete medium) at 37°C, 5% CO2.

Hc and Sc

Hc strain G217B was maintained on brain heart infusion agar and cultured in quantity at 37°C in Hams F12 supplemented with cystine (8.4 µg/L), HEPES (6 g/L), glutamic acid (1 g/L), and glucose (18.2 g/L) (21). The yeast phase was maintained at 37°C. Sc was maintained on YEPD (1% yeast extract, 2% peptone, 2% dextrose) plates and cultured in quantity in the identical medium used to culture Hc.

FITC-labeled Sc and Hc

Yeasts were cultured to midlog phase and then collected by centrifugation. The yeast pellet was resuspended in 0.5 M carbonate/bicarbonate buffer, pH 9.4, containing 10 µg/ml FITC, and incubated in the dark for 15 min at room temperature. For certain experiments, the yeasts then were washed twice and resuspended in Hypo-K buffer (hyposmotic—150 mOsm): 71 mM KCl, 1.8 mM CaCl2, 10 mM HEPES, 0.17 mM K2HPO4, 0.175 mM KH2PO4, 0.405 mM MgSO4, and 2 mg/ml BSA (pH 7.2)). In other experiments, the yeasts were washed and suspended in HBSS containing 0.2% BSA (HBSA). FITC-labeled yeast and unlabeled yeast were always greater than 98% viable as determined by trypan blue dye exclusion.

Binding and ingestion of FITC-labeled yeasts

FITC-labeled yeasts were incubated with monolayers of Mø for 1 h in HBSA in the presence or absence of 25 nM bafilomycin. Unbound yeast was then removed by washing, and the monolayers were incubated for 10 min at room temperature in 0.1% trypan blue in HBSA. The cells then were washed with HBSA and fixed overnight at 4°C in HBSA containing 1% paraformaldehyde. Ingested vs bound yeasts were quantified as described previously (22).

Intracellular replication of Hc

The intracellular growth of Hc was quantified by RIA as described previously (17). Mø were cultured in 96-well plates and used when approximately 50% confluent. Prior to infection, aggregated Hc yeasts were pelleted (500 x g for 5 min) and discarded. A total of 5 x 103 yeasts in complete medium were incubated with Mø for 1 h to allow for phagocytosis, and then postendocytic inhibitors were added (10 µM chloroquine or 25 nM bafilomycin). Monolayers were cultured for 24 h, after which the medium was aspirated and 5 µl 10x yeast nitrogen broth and 50 µl of water containing 1.0 µCi of [3H]leucine were added to each well. The cultures then were incubated at 37°C for an additional 24 h, after which 50 µl of unlabeled leucine (10 mg/ml) and 50 µl of bleach were added to each well. The contents of the wells then were harvested onto glass fiber filters, unincorporated tritium was removed by extensive washing, and the incorporated tritium was quantified via scintillation counting. The data are presented as the percentage of inhibition of growth which is defined as:

"Synchronized" infection of Mø with yeasts

In certain experiments the ingestion of yeast was synchronized by permitting binding but blocking internalization with hypo-K buffer (23). Monolayers were washed with hypo-K buffer and then were incubated with washed yeast in hypo-K buffer for 1 h at 37°C. Unless stated otherwise the ratio of Hc to Mø was 10:1. The monolayers then were washed a minimum of five times with hypo-K buffer to remove unbound yeast. The absence of unbound yeast was confirmed by microscopy. The infected monolayers then were cultured in complete medium under normal growth conditions for varying periods of time.

Quantitation of pH in yeast-containing phagosomes

Mø cultured on coverslips were incubated with FITC-labeled yeasts in hypo-K buffer for 1 h at 37°C. Unbound yeasts were washed away and the Mø then were cultured in complete medium for 2 h to allow ingestion and phagosomal maturation. After the 2-h maturation period, bafilomycin was added to one-half of the cells at a final concentration of 25 nM. Mø were incubated in complete medium for 2 h longer, after which the cells were washed with HBSS lacking phenol red and placed on ice. Prior to fluorometry the monolayers were rinsed with ice-cold 10 mM phosphate buffer at pHs ranging from 4.0 to 7.0. The fluorescence was determined on a Perkin-Elmer (Norwalk, CT) spectrofluorometer at both 450-nm and 490-nm excitation wavelengths and an emission wavelength of 515 nm. After the fluorescence of the intact phagosomes had been determined, the phagosomes were permeabilized with 0.1% Triton X-100. The fluorescence of phagosomes permeabilized in different pH buffers was used to generate a pH curve from which the pH of intact phagosomes was determined.

Acid phosphatase

Mø were infected with yeasts for 1 h at 37°C in hypo-K buffer, unbound yeast was washed away, and the phagosomes were allowed to mature for 4.5 h or 24 h in complete medium. Cells were washed with HBSS, fixed for 30 min at 4°C with 2% glutaraldehyde in cold sodium cacodylate buffer (SCB) (0.1 M sodium cacodylate, 0.25 M sucrose, pH 7.4), and then washed again with SCB. Washing was followed by two 30-min incubations in acid phosphatase reaction buffer (0.1 M sodium acetate, 1 mM glycerophosphate, and 2 mM CeCl3), pH 5.2, at 37°C with gentle shaking. Thereafter the cells were rinsed three times with the acid phosphatase reaction buffer, and refixed in 3% glutaraldehyde in SCB for 1 h at 4°C. After three more washes in SCB, monolayers were postfixed with 1% osmium tetroxide in cold SCB. The cells then were washed, dehydrated, and embedded in Epon. Ultrathin sections were cut and subsequently viewed on a Joel 100CX electron microscope.

Postembedding immunoelectron microscopy

Mø were infected with yeasts for 1 h in hypo-K buffer. At each time point, yeast-containing Mø were rinsed twice with hypo K buffer and then fixed in PLP (2% paraformaldehyde, 0.01 M periodate, 0.075 M lysine, and 0.075 M phosphate buffer, made fresh) for 2 h at room temperature after which the cells were washed with SCB, postfixed with freshly reduced 1% osmium tetroxide, and then dehydrated and embedded in Epon. Ultrathin sections were cut and the plastic etched by exposure to 5% NaIO4 (twice, 30 min each). The samples were blocked in PBS containing 10% normal goat serum and 1% fish gelatin followed by an overnight incubation with the indicated Ab (rabbit anti-mouse LAMP2, rabbit anti-V-ATPase subunit E, rabbit anti-V-ATPase subunit Ac115, or rabbit anti-horse spleen ferritin as a negative control) at room temperature in a humidified chamber. The sections then were washed extensively and incubated with biotinylated goat anti-rabbit IgG (in block at 50 µg/ml) for 1 h at room temperature. The sections were extensively washed and incubated with 10 nM gold coupled to Streptavidin (24) for 1 h at room temperature. The sections again were washed vigorously, stained with 2% uranyl acetate for 30 min, and then rinsed with water. The sections then were viewed on a Joel 100CX electron microscope. Gold particles were counted in the proximity of the yeast cell wall only if the yeast appeared to be in intact cells.

V-ATPase abs

For the V-ATPase subunit E, rabbit polyclonal antiserum was raised to a fusion of the T7 gene 9 protein with the entire coding region of the mouse subunit E (25). The serum was immunoadsorbed with immobilized T7 gene 9 protein and then affinity purified with immobilized subunit E fusion protein prior to use (26). For Ac115, a fusion protein consisting of a conserved region corresponding to amino acids 661–717 of the rat protein fused to T7 gene 9 was used to immunize rabbits. Serum was collected and immunoadsorbed with immobilized T7 gene 9 protein and then affinity purified with immobilized Ac115 fusion protein prior to use (26).

Cationized ferritin

Mø monolayers were infected with yeasts for 1 h in hypo-K buffer and the phagosomes allowed to mature for 4.5 h. Cationized ferritin was added to the monolayers at a concentration of 0.5 mg/ml in complete medium for 30 min. The monolayers then were washed twice with SCB, fixed for 2 h in PLP at 25°C, and then processed for electron microscopy. Phagosomes in intact cells were scored for the presence or absence of ferritin.

PL fusion

Mø monolayers growing on coverslips were cultured overnight in the presence of 50 µg/ml of rhodamine-coupled dextran (70,000 m.w.; Sigma). Excess dextran then was removed by three washes with HBSS, and the cells were cultured in complete medium for 5 h. The Mø then were infected with FITC-labeled yeasts in hypo-K buffer for 1 h after which unbound yeasts were removed, and the infected monolayer was incubated in complete medium. At 5 h postinfection the Mø were washed twice in HBSS and then fixed overnight at 4°C with 1% paraformaldehyde in hypo-K buffer. Mø then were rinsed, mounted, and viewed on a Zeiss fluorescent microscope. Phagosomes were scored positive for lysosomal fusion when a red rim surrounded green yeast.

Statistical analysis

Statistical significance was determined using Student’s t test or a Kruskal-Wallis nonparametric ANOVA test, depending on the data.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Phagosomal V-ATPase

We first sought to determine if disruption of V-ATPase activity affected the capacity of Hc yeasts to replicate within RAW Mø. Mø were infected with Hc, bafilomycin was added at 1 h postinfection, and the cells were cultured for an additional 24 h. After the 24-h incubation, the number of viable yeasts was quantified by the incorporation of [3H]leucine as described in Materials and Methods. Remarkably, bafilomycin had no effect on the intracellular growth of Hc yeasts (Fig. 1Go). In contrast, coculture with the weak base chloroquine inhibited intracellular replication by 70%. The effect of chloroquine was identical to that observed in human Mø (17).



View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 1. Bafilomycin does not inhibit the intracellular replication of Hc. RAW264.7 Mø were cultured in 96-well tissue culture plates and infected with 5 x 103 Hc yeasts when ~50% confluent. At 1 h postinfection, chloroquine (10 µM) or bafilomycin (25 nM) was added to the cultures. After a further 24 h of culture, intracellular replication was quantified as described in Materials and Methods. Results are the mean ± SEM of three separate experiments.

 
To confirm that exposure to bafilomycin did not affect the ability of the Mø to phagocytose Hc yeasts, binding and ingestion were quantified by incubating Mø with FITC-labeled Hc for 1 h in the presence or absence of bafilomycin and subsequently counting the number of bound vs ingested yeasts. Mø incubated with bafilomycin ingested 2.87 ± 0.3 (mean ± SEM) Hc yeasts/Mø compared with 2.93 ± 0.4 for control Mø. In addition, the percentage of Mø containing Hc yeasts also was the same (47.4 ± 4.4%, 44.1 ± 5.3%) for control and bafilomycin-treated Mø, respectively.

To determine the effect of bafilomycin on phagosomal pH, Hc was labeled with the pH-sensitive dye FITC. FITC-labeled methanol-killed Hc and live Sc served as controls. The labeled yeasts were incubated with Mø for 1 h, after which unbound yeasts were removed by washing. Because acidification is required for phagosomal maturation (27, 28, 29), the yeast-containing phagosomes were allowed to mature for 2 h prior to the addition of bafilomycin followed by a 2-h incubation in the presence of bafilomycin. In agreement with previous studies (13), in the absence of bafilomycin, phagosomes containing either dead Hc or live Sc acidified normally to a pH of approximately 4.8, whereas phagosomes containing live Hc were at a pH of about 6.3 (Fig. 2Go). In the presence of bafilomycin the pH of phagosomes containing dead Hc or viable Sc increased to neutral, indicating that bafilomycin had disrupted phagosomal V-ATPase activity (Fig. 2Go). In contrast, the pH of phagosomes containing live Hc was unaffected by bafilomycin. These data suggest that Hc does not require the V-ATPase to acidify the phagosome.



View larger version (51K):
[in this window]
[in a new window]
 
FIGURE 2. Bafilomycin does not affect the pH of Hc-containing phagosome. Mø were infected with FITC-labeled Hc and Sc, and unbound yeasts were removed by washing. Phagosomes were allowed to mature for 2 h at which time bafilomycin (25 nM) was added to some of the monolayers, and Mø then were cultured an additional 2 h. The relative fluorescence then was measured (using the ratio of 450:490 nm excitation and 515 nm emission), and pH determined from a standard curve generated by using different pH buffers with lysed phagosomes. Because of the slightly different fluorescence properties of the live and dead Hc and Sc, separate pH curves were generated for each organism. The data are the mean ± SEM of three experiments.

 
The V-ATPase is present at reduced levels in phagosomes containing viable Hc yeasts

As phagosomes mature, they accrue V-ATPase and become more acidic (18, 19, 20). As the Hc-containing phagosome is held at pH 6.3, but does not require the phagosomal V-ATPase to maintain this pH, we next sought to quantify the relative levels of V-ATPase present in the phagosomal membranes of RAW Mø by immunoelectron microscopy using Abs specific for the V-ATPase subunits Ac115 and E. Mø were infected with Hc for 1 h in hypo-K buffer, which permitted the yeasts to bind to Mø but prevented internalization (23). After 1 h, the unbound yeasts were removed, and ingestion and maturation allowed to proceed for 4.5 h whereupon monolayers were fixed and processed using affinity-purified V-ATPase antisera as described in Materials and Methods. The results obtained with the two Abs were identical and demonstrated that the phagosomal membranes surrounding live Hc contained V-ATPase at 3- to 4-fold lower levels than phagosomes containing Sc (Fig. 3Go). Phagosomes containing methanol-killed Hc contained an intermediate level of V-ATPase. The level of V-ATPase in phagosomes containing live Hc remained unchanged up to 24 h postinfection (data not shown). There were no detectable killed Hc- or Sc-containing phagosomes at time points later than 8 h, as all of the yeasts were digested.



View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 3. Hc-containing phagosomes contain decreased levels of the phagosomal V-ATPase. Hc- and Sc-infected monolayers were fixed at 4.5 h postinfection and imbedded in Epon. Ultrathin sections then were etched and stained for the presence of V-ATPase subunits E and Ac115, using affinity-purified rabbit polyclonal Abs, and viewed using indirect immunogold labeling. A minimum of 30 phagosomes were counted per data point. The data are presented as the number of gold particles per yeast-containing phagosome, and are the mean ± SEM of three separate experiments. There was a statistically significant decrease in the levels of V-ATPase present in the membranes of Hc-containing phagosomes compared with Sc-containing phagosomes (p < 0.0001).

 
Hc yeasts inhibit PL fusion

As the V-ATPase was inhibited from accumulating in Hc-containing phagosomes, we next reexamined the question of PL fusion in RAW Mø. Previous studies with the P388D1 mouse Mø cell line (14) and murine resident peritoneal Mø (15) reported normal PL fusion upon phagocytosis of Hc yeasts. In contrast, human Mø demonstrated minimal PL fusion after phagocytosis of Hc (16). To quantify PL fusion, FITC-labeled yeasts were incubated in hypo-K buffer with Mø whose lysosomes were pre loaded with rhodamine B-isothiocyanate-labeled dextran (RITC-dextran). At 5 h postinfection, 20% of Hc-containing phagosomes had a red rim, indicating fusion with an RITC-dextran containing lysosome (Fig. 4Go). No increase in PL fusion was observed up to 24 h postinfection (data not shown). In contrast, greater than 90% of Sc-containing phagosomes fused with lysosomes at 5 h postinfection, and phagosomes containing dead Hc showed an intermediate phenotype (Fig. 4Go).



View larger version (55K):
[in this window]
[in a new window]
 
FIGURE 4. Hc yeasts inhibit PL-fusion. Mø were loaded with rhodamine-coupled dextran overnight, external rhodamine was removed by washing, and the Mø were incubated for a further 6 h to allow the dextran-containing vesicles to mature. The monolayers then were infected with FITC-labeled yeasts and the percentage of yeast in rhodamine-containing compartments was quantified by counting a minimum of 100 phagosomes. The data are the mean ± SEM for three separate experiments.

 
To further characterize the level of phagosomal maturation, we quantified the fraction of acid phosphatase-positive phagosomes. Monolayers were infected with yeasts in hypo-K buffer for 1 h, then the unbound yeasts were washed away and the phagosomes were allowed to mature for 4.5 h, after which they were fixed and stained for acid phosphatase activity. The acid phosphatase data closely parallels the RITC-dextran data. At 4.5 h postinfection, about 20% of Hc-containing phagosomes stained positive for acid phosphatase, whereas greater than 90% of Sc-containing phagosomes were positive for acid phosphatase. Mø containing killed Hc again showed an intermediate amount of staining (Fig. 5Go). The percentage of Hc-containing phagosomes that were acid phosphatase positive was unchanged at 24 h postinfection in Mø containing viable Hc, indicating that Hc remained viable after PL fusion. Thus, RAW Mø appear to behave like human Mø (16) in that PL fusion is minimal compared with the PL fusion that occurs upon ingestion of Sc yeasts.



View larger version (60K):
[in this window]
[in a new window]
 
FIGURE 5. Hc inhibits the acquisition of acid phosphatase into Hc-containing phagosomes. Mø infected with viable or killed Hc or viable Sc were stained for the presence of acid phosphatase at 4.5 h postinfection. A minimum of 100 phagosomes were counted for each condition and scored solely as positive or negative. The data are presented as the mean ± SEM of the percentage of acid phosphatase-positive phagosomes for each of three separate experiments.

 
We next used quantitative immunoelectron microscopy to determine the levels of the late endosomal/lysosomal marker, LAMP2. Monolayers were infected with Hc in hypo-K buffer for 1 h, whereupon unbound yeasts were removed, and Mø further cultured for 4.5 h to permit phagosomal maturation. The monolayers then were fixed and processed as described in Materials and Methods. Phagosomes containing viable Hc had approximately one-half of the number of LAMP2 molecules as in Sc-containing phagosomes (Fig. 6Go). All of the viable Hc-containing phagosomes contained equivalent levels of LAMP2, indicating that the decreased levels of LAMP in the phagosomal membrane is not the result of a subset of phagosomes that do not mature.



View larger version (58K):
[in this window]
[in a new window]
 
FIGURE 6. Hc-containing phagosomes have diminished levels of LAMP2. Hc- and Sc-infected monolayers were fixed 4.5 h postinfection and embedded in Epon. Ultrathin sections then were etched and stained for the presence of LAMP using rabbit polyclonal anti-mouse LAMP2 Abs. A minimum of 30 phagosomes were counted per data point. The data are the mean ± SEM of three separate experiments. The amount of LAMP2 in viable Hc-containing phagosomes was significantly less than in Sc-containing phagosomes (p < 0.0001).

 
If intracellular Hc acquires iron directly from transferrin as the chloroquine data suggest (17), then the phagosome must have access to an "early" endosomal compartment. Endocytic access was assayed 4.5 h postinfection by incubating Mø with cationized ferritin for 30 min and the extent of endosomal fusion quantified by electron microscopy. In monolayers infected with viable Hc 60.9 ± 5% (mean ± SEM) of the phagosomes contained ferritin, indicating that they had fused with at least one endosome. Endocytic fusion was comparable in phagosomes containing killed Hc (55.2 ± 4.4%) or viable Sc (54.3 ± 4.3%).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Hc survives and multiplies in what should be a potent antimicrobial environment, the Mø phagosome. As Hc does not appear to release factors that globally affect Mø function (12, 13), its survival strategy must be to control its intraphagosomal environment. Previous studies have demonstrated that Hc-containing phagosomes are at a slightly acidic pH of about 6.5 (13). This pH allows Hc yeasts to access iron from transferrin, and at the same time presumably minimize the detrimental effects of lysosomal hydrolases (17). The mechanisms by which Hc yeasts maintain a phagosomal pH of 6.5 are unknown. The V-ATPase appears to be responsible for generating the acidic pH of many phagosomes (18, 19, 20). Therefore, we sought to determine the role of the phagosomal V-ATPase in the acidification of Hc-containing phagosomes.

Surprisingly, the V-ATPase specific inhibitor, bafilomycin, did not affect the ability of intracellular Hc to survive, nor did it cause a change in intraphagosomal pH. In contrast, methanol-fixed Hc and viable Sc were found in acidic phagosomes (approximately pH 4.8) and the pH increased to neutral in the presence of bafilomycin. Similar results were seen using antisense oligonucleotides directed to various subunits of the V-ATPase (data not shown). These data suggest that Hc actively senses pH and maintains it at 6.3. Interestingly, while externally replicating Hc alkalinizes the medium (data not shown), it does not buffer it to pH 6.3, suggesting that unique mechanisms are involved when the fungus is inside of the Mø phagosome. An understanding of the sensing mechanisms involved as well as the mechanisms used to maintain phagosomal pH should shed significant insight into the survival strategy of the fungus as well as providing possible drug targets.

The fact that Hc-containing phagosomes take up cationized ferritin indicates that they have full access to the early endocytic pathway. In contrast, the low levels of LAMP2, V-ATPase, lysosomal fusion, and acid phosphatase in Hc-containing phagosomes demonstrate decreased maturation compared with Sc-containing phagosomes. The differences in levels of expression of these markers are not the result of some macrophages killing Hc while in other macrophages the phagosomes do not mature at all. In each case, the variability in expression was the same when examining multiple phagosomes within a macrophage or comparing phagosomes from different macrophages. It is unclear why all of the phagosomes examined expressed low levels of LAMP2, but only one-fourth fused with lysosomes or contained lysosomal enzymes. These observations suggest that Hc may differentially modulate fusion with distinct vesicle populations.

There is contradictory data regarding the extent to which Hc-containing phagosomes fuse with lysosomes. In mouse peritoneal Mø, J774.2 Mø, and P388D1 Mø, PL fusion occurs normally (14, 15) compared with Sc, whereas in human Mø, PL fusion is inhibited compared with Sc (16). In the present experiments with RAW Mø, we found that Hc-containing phagosomes fuse with lysosomes at a low level compared with Sc and that fusion had no apparent effect on the viability of the Hc. Furthermore, approximately the same percentage of phagosomes contained acid phosphatase as fused with RITC-dextran-loaded lysosomes. Thus, RAW Mø function similarly to human Mø with respect to inhibition of PL fusion (16).

Although these disparate results might be caused by different methods used to quantify lysosomal fusion or by Hc strain variations, the most likely explanation is that the different Mø populations simply function differently with respect to their interaction with Hc yeasts. Indeed, this is a common theme in the Hc literature, and the literature of other pathogenic microorganisms. Thus, RAW (30, 31) and mouse peritoneal Mø (32, 33) are activated by IFN-{gamma} to inhibit the intracellular growth of Hc yeasts through the production of nitric oxide, whereas human Mø (34, 35) and the murine Mø cell lines P388D1 and IC-21 (36) are not activated to an antihistoplasma state by IFN-{gamma}, presumably because of their inability to produce nitric oxide under the experimental conditions studied. Furthermore, phagocytosis of unopsonized Hc yeasts stimulates a vigorous respiratory burst in human Mø (37), but not in murine Mø (38, 39). However, phagocytosis of IgG-opsonized Hc yeasts by murine Mø does stimulate the respiratory burst (40). It is important to note that the differences in the interactions between Mø and Hc yeasts do not sort out according to species, or whether the Mø is "normal" or a tumor cell line. These observations, along with others, reinforce the fact that data generated from individual Mø pathogen studies cannot necessarily be interpreted globally.

The intermediate phenotype exhibited by Mø phagosomes containing methanol-fixed Hc yeasts is intriguing but its cause is unknown. RAW Mø phagosomes containing methanol-killed Hc acidify normally at 4.5 h postinfection, but have intermediate levels of V-ATPase, lysosomal fusion, and acid phosphatase, compared with viable Hc- and Sc-containing phagosomes. One possible explanation relates to the signal transduction pathway that is activated during phagocytosis of Hc yeasts. Although uncharacterized, ligands on Hc that bind to Mø CD18 (22, 37) presumably survive methanol fixation as fixed yeasts are ingested as rapidly as viable yeasts. Thus, observed levels of V-ATPase, acid phosphatase, and PL fusion may be the result of intracellular signaling induced via interaction with Mø CD18. However, whatever causes the initial inhibition of phagosomal maturation seen with methanol-fixed Hc, the inhibition is short lived, as the yeasts are fully digested by 8 h.

Although intracellular pathogens of Mø have evolved unique survival mechanisms, the strategies utilized by Hc and Mycobacterium spp. (Mb) are remarkably similar. Both Hc and Mb exist in a phagosome with a pH of approximately 6.3 (13, 41, 42), retain the ability to fuse with early endosomes (Refs. 41 and 43–45; this paper), and fuse with lysosomes at decreased levels (Refs. 16, 42, 43, and 45–47; this paper). The major difference between Mb- and Hc-containing phagosomes is that Mb-containing phagosomes have no detectable V-ATPase (41, 45, 47, 48), whereas phagosomes containing Hc contain V-ATPase albeit at diminished levels relative to Sc. However, the V-ATPase is not necessary to maintain the pH of phagosomes containing Hc as treatment with bafilomycin does not alter phagosomal pH. Intriguingly, while there is no detectable V-ATPase in Mb-containing phagosomes, exposure to bafilomycin does raise the phagosomal pH to neutral (49). While it is unclear why bafilomycin treatment raises the pH of Mb-containing phagosomes, it is clear that the phagosomal V-ATPase is not required for the acidification of phagosomes containing Hc, indicating that the pathogens use different mechanisms to modify phagosomal pH.

While the V-ATPase is the enzyme that generates the acidic pH of most phagosomes (18, 19, 20), proton pumping by the V-ATPase is not the only mechanism by which phagosomes could acidify. Other proteins that are present in the plasma membrane may be present and active in the phagosome and could generate an acidic pH in the phagosome. Hc could use the Na+/H+ exchanger (NHE) to acidify phagosomes. Interestingly, NHE is present in Mb-containing phagosomes, but is not necessary for generating or maintaining the phagosomal pH (49). For NHE to acidify the phagosome, it would likely require the presence of the Na+/K+ ATPase, but this enzyme is not detectable in Mb-containing phagosomes (49). We speculate that Hc may somehow recruit the Na+/K+ ATPase to the phagosomal membrane or otherwise activate NHE (or another protein) to acidify the phagosome. Alternatively, Hc may directly acidify the phagosome itself. Given the delicate balance required for Hc to access iron while minimizing the activity of acid hydrolases, Hc likely has a pH sensor with which it monitors the pH of its environment, responding as necessary to changes in pH.


    Acknowledgments
 
We thank Dr. Bruce Granger for the generous gift of anti-mouse LAMP2 Abs and Prof. K. Altendorf for the gift of bafilomycin.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants GM39555 (to G.E.D.), AI28392 (to G.E.D.), and AI37639 (to S.L.N.). Back

2 Address correspondence and reprint requests to Dr. Jane Strasser, Division of Infectious Diseases, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. E-mail address: Back

3 Abbreviations used in this paper: Hc, Histoplasma capsulatum; Mø, macrophage; Sc, Saccharomyces cerevisiae; Mb, Mycobacterium spp.; V-ATPase, vacuolar ATPase; NHE, Na+H+ exchanger; PL fusion, phagolysosomal fusion; HBSA, HBSS containing 0.2% BSA; RITC-dextran, rhodamine B-isothiocyanate-labeled dextran; SCB, sodium cacodylate buffer. Back

Received for publication November 5, 1998. Accepted for publication March 1, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Reddy, P., D. F. Gorelick, C. A. Brasher, H. Larsh. 1970. Progressive disseminated histoplasmosis as seen in adults. Am. J. Med. 48:629.[Medline]
  2. Smith, J. W., J.P. Utz. 1972. Progressive disseminated histoplasmosis: a prospective study of 26 patients. Ann. Intern. Med. 76:557.
  3. Davies, S. F., M. Khan, G. A. Sarosi. 1978. Disseminated histoplasmosis in immunologically suppressed patients: occurrence in a nonendemic area. Am. J. Med. 64:94.[Medline]
  4. Kaufman, C. A., K. S. Israel, J. W. Smith, A. C. White, J. Schwartz, G. F. Brooks. 1978. Histoplasmosis in immunosuppressed patients. Am. J. Med. 64:923.[Medline]
  5. Wheat, L. J., E. J. Smith, B. Sathapatyavongs, B. Batteiger, R. S. Filo, S. V. Leapman, M. V. French. 1982. Risk factors for disseminated or fatal histoplasmosis. Ann. Intern. Med. 96:159.
  6. Wheat, L. J., E. J. Smith, B. Sathapatyavongs, R. S. Batteiger, S. V. Leapman Filo, M. V. French. 1983. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch. Intern. Med. 143:703.[Abstract]
  7. Graybill, J. R.. 1988. Histoplasmosis in AIDS. J. Infect. Dis. 158:623.[Medline]
  8. Kurtin, P. J., D. S. McKinsey, M. R. Gupta, M. Driks. 1990. Histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Clin. Pathol. 93:367.[Medline]
  9. Deepe, G. S., W. E. Bullock. 1992. Histoplasmosis: a granulomatous inflammatory response. J. I. Gallin, and I. M. Goldstein, and R. Snyderman, eds. Inflammation: Basic Principles and Clinical Correlates 943. Raven Press, New York.
  10. Baughman, R. P., D. K. Kim, A. Vinegar, E. E. Hendricks, D. J. Schmidt, W. E. Bullock. 1986. The pathogenesis of experimental pulmonary histoplasmosis: correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am. Rev. Respir. Dis. 134:771.[Medline]
  11. Newman, S. L., W. E. Bullock. 1993. Interaction of Histoplasma capsulatum yeasts and conidia with human and animal macrophages. B. S. Zwifling, and T. Einsenstein, eds. Macrophage Pathogen Interactions 517. Marcel Dekker, New York.
  12. Newman, S. L., L. Gootee, R. Morris, W. E. Bullock. 1992. Digestion of Histoplasma capsulatum yeasts by human macrophages. J. Immunol. 149:574.[Abstract]
  13. Groppe-Eissenberg, L., W. E. Goldman, P. H. Schlesinger. 1993. Histoplasma capsulatum modulates the acidification of phagolysosomes. J. Exp. Med. 177:1605.[Abstract/Free Full Text]
  14. Groppe-Eissenberg, L., P. H. Schlesinger, W. E. Goldman. 1988. Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J. Leukocyte Biol. 43:483.[Abstract]
  15. Taylor, M. L., M. E. Espinosa-Schoelly, R. Iturbe, B. Rico, J. Casasola, F. Goodsaid. 1989. Evaluation of phagolysosome fusion in acridine orange stained macrophages infected with Histoplasma capsulatum. Clin. Exp. Immunol. 75:466.[Medline]
  16. Newman, S. L., L. Gootee, C. Kidd, G. M. Ciraolo, R. Morris. 1997. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices. J. Immunol. 158:1779.[Abstract]
  17. Newman, S. L., L. Gootee, G. Brunner, Jr G. S. Deepe. 1994. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest. 93:1422.
  18. Pitt, A., L. S. Mayorga, P. D. Stahl, A. L. Schwartz. 1992. Alterations in the protein composition of maturing phagosomes. J. Clin. Invest. 90:1978.
  19. Lukacs, G. L., O. D. Rotstein, S. Grinstein. 1990. Phagosomal acidification is mediated by a vacuolar-type H+ ATPase in murine macrophages. J. Biol. Chem. 265:21099.[Abstract/Free Full Text]
  20. Lukacs, G. L., O. D. Rotstein, S. Grinstein. 1991. Determinants of phagolysosomal pH in macrophages. J. Biol. Chem. 266:24540.[Abstract/Free Full Text]
  21. Worsham, P., W. E. Goldman. 1988. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J. Med. Vet. Mycol. 26:137.[Medline]
  22. Newman, S. L., C. Bucher, J. Rhodes, W. E. Bullock. 1990. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages: cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest. 85:223.
  23. McVey-Ward, C., C. M. Perou, M. Lloyd, J. Kaplan. 1995. "Synchonized" endocytosis and intracellular sorting in alveolar macrophages: the early sorting endosome is a transient organelle. J. Cell Biol. 129:1229.[Abstract/Free Full Text]
  24. Morris, R. E., C. B. Saelinger. 1990. Visualization of intracellular trafficking of proteins by the biotinyl-ligand: avidin-gold method. Methods Enzymol. 184:379.[Medline]
  25. Laitala, -L, T. einonen, M. L. Howell, G. E. Dean, H. K. Vaananen. 1996. Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts. Mol. Biol. Cell. 7:129.[Abstract]
  26. Harlow, D., D. Lane. 1988. Antibodies: a Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
  27. Gordon, A. H., P. D’Arcy-Hart, M. R. Young. 1980. Ammonia inhibits phagosome lysosome fusion in macrophages. Nature 286:79.[Medline]
  28. Bouvier, G., A. M. Benoliel, C. Foa, P. Bongrand. 1994. Relationship between phagosome acidification, phagosome-lysosome fusion, and mechanism of particle ingestion. J. Leukocyte. Biol. 55:729.[Abstract]
  29. Desjardins, M., L. A. Huber, R. G. Parton, G. Griffiths. 1994. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124:677.[Abstract/Free Full Text]
  30. Nakamura, L. T., B. A. Wu-Hsieh, D. H. Howard. 1994. Recombinant murine {gamma} interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62:680.[Abstract/Free Full Text]
  31. Lane, T. E., G. C. Otero, B. A. Wu-Hsieh, D. H. Howard. 1994. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun. 4:1478.
  32. Wu-Hsieh, B. A., D. H. Howard. 1987. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine interferon-{gamma}. Infect. Immun. 55:1014.[Abstract/Free Full Text]
  33. Lane, T. E., B. A. Wu-Hsieh, D. H. Howard. 1994. Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect. Immun. 5:1940.
  34. Fleischmann, J., B. Wu-Hsieh, D. H. Howard. 1990. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant interferon-{gamma}. J. Infect. Dis. 161:143.[Medline]
  35. Newman, S. L., L. Gootee. 1992. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immun. 60:4593.[Abstract/Free Full Text]
  36. Wu-Hsieh, B., D. H. Howard. 1989. Macrophage cell lines P388D1 and IC-21 stimulated with {gamma} interferon fail to inhibit the intracellular growth of Histoplasma capsulatum. Infect. Immun. 57:2903.[Abstract/Free Full Text]
  37. Bullock, W. E., S. D. Wright. 1987. Role of adherence-promoting receptors, CR3, LFA-1, and p150–95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165:195.[Abstract/Free Full Text]
  38. Groppe-Eissenberg, L., W. E. Goldman. 1987. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect. Immun. 55:29.[Abstract/Free Full Text]
  39. Wolf, J. E., A. L. Abegg, S. J. Travis, G. S. Kobayashi, J. R. Little. 1989. Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect. Immun. 57:513.[Abstract/Free Full Text]
  40. Wolf, J. E., V. Kerchberger, G. S. Kobayashi, J. R. Little. 1987. Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J. Immunol. 138:582.[Abstract]
  41. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263:678.[Abstract/Free Full Text]
  42. Oh, Y. K., R. M. Straubinger. 1996. Intracellular fate of Mycobacterium avium: use of dual label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction. Infect. Immn. 64:319.[Abstract]
  43. Russell, D. G., J. Dant, S. Sturgill-Koszycki. 1996. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol. 156:4764.[Abstract]
  44. Sturgill-Koszycki, S., U. E. Shiable, D. G. Russell. 1996. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15:6960.[Medline]
  45. Xu, S., A. Cooper, S. Sturgill-Koszycki, T. van Heynigen, D. Chatterjee, I. Orme, P. Allen, D. G. Russell. 1994. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol. 153:2568.[Abstract]
  46. DeChastellier, C., C. Frehel, C. Offredo, E. Skamene. 1993. Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice. Infect. Immun. 61:3775.[Abstract/Free Full Text]
  47. Clemens, D. L., M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257.[Abstract/Free Full Text]
  48. De Chastellier, C., T. Lang, L. Thilo. 1995. Phagocytic processing of the macrophage endoparasite, Mycobacterium avium, in comparison to phagosomes which contain Bacillus subtilis or latex beads. Eur. J. Cell Biol. 68:167.[Medline]
  49. Hackam, D. J., O. D. Rotstein, W. J. Zhang, N. Demaurex, M. Woodside, O. Tsai, S. Grinstein. 1997. Regulation of phagosomal acidification: differential targeting of Na+/H+ exchangers, Na+/K+-ATPases and vacuolar type H+-ATPases. J. Biol. Chem. 272:29810.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eukaryot CellHome page
L. Shi, P. C. Albuquerque, E. Lazar-Molnar, X. Wang, L. Santambrogio, A. Gacser, and J. D. Nosanchuk
A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages
Eukaryot. Cell, July 1, 2008; 7(7): 1109 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Newman, L. Gootee, J. Hilty, and R. E. Morris
Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum
J. Immunol., February 1, 2006; 176(3): 1806 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Gildea, G. M. Ciraolo, R. E. Morris, and S. L. Newman
Human Dendritic Cell Activity against Histoplasma capsulatum Is Mediated via Phagolysosomal Fusion
Infect. Immun., October 1, 2005; 73(10): 6803 - 6811.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. A. Cox and D. M. Magee
Coccidioidomycosis: Host Response and Vaccine Development
Clin. Microbiol. Rev., October 1, 2004; 17(4): 804 - 839.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. M. Timmerman and J. P. Woods
Potential Role for Extracellular Glutathione-Dependent Ferric Reductase in Utilization of Environmental and Host Ferric Compounds by Histoplasma capsulatum
Infect. Immun., December 1, 2001; 69(12): 7671 - 7678.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. G. Rittig, M.-T. Alvarez-Martinez, F. Porte, J.-P. Liautard, and B. Rouot
Intracellular Survival of Brucella spp. in Human Monocytes Involves Conventional Uptake but Special Phagosomes
Infect. Immun., June 1, 2001; 69(6): 3995 - 4006.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strasser, J. E.
Right arrow Articles by Dean, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strasser, J. E.
Right arrow Articles by Dean, G. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS